Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Risk of Stroke in Children
Neurol 61:189-194, Fullerton,H.J.,et al, 2003
Stroke in the Young in the Northern Manhattan Stroke Study
Stroke 33:2789-2793, Jacobs,B.S.,et al, 2002
Barriers to Acute Stroke Therapy and Stroke Prevention in Mexican Americans
Stroke 32:1360-1364, Morgenstern,L.B.,et al, 2001
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
Stroke in Children and Sickle-Cell Disease, Baltimore-Washington Cooperative Young Stroke Study
Neurol 51:169-176, Earley,C.J.,et al, 1998
Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998
Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998
Stroke in Young Black Patients:Risk Factors, Subtypes, & Prognosis
Stroke 26:1995-1998, Qureshi,A.I.,et al, 1995